百合股份: 威海百合生物技术股份有限公司第四届董事会第十三次会议决议公告

Group 1 - The board of directors of Weihai Bihua Biotechnology Co., Ltd. held its 13th meeting on August 29, 2025, with all 9 directors present, confirming compliance with relevant laws and regulations [1] - The board approved the 2025 semi-annual report and its summary with a unanimous vote of 9 in favor [2] - The board also approved a special report on the storage and actual use of raised funds for the first half of 2025, again with a unanimous vote of 9 in favor [2] Group 2 - The board resolved to cancel the supervisory board and amend the company’s articles of association, transferring the supervisory functions to the audit committee of the board, with a unanimous vote of 9 in favor [3] - The board approved the revision and establishment of internal governance systems to enhance management and governance structure, with a unanimous vote of 9 in favor [3] - The board proposed to hold the first extraordinary general meeting of shareholders in 2025 on September 26, 2025, to review the resolutions submitted by the board [3]